Influence of plasminogen deficiency on the contribution of polymorphonuclear leucocytes to fibrin/ogenolysis: Studies in plasminogen knock-out mice

Thrombosis and Haemostasis

Volumn 88, Issue 5, 2002, Pages 805-810

  Zeng, Biao ^a   Bruce, David ^a   Kril, Jillian ^a   Ploplis, Victoria ^a   Freedman, Ben ^a   Brieger, David ^a  

^a Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

Fibrinolysis; Plasminogen deficiency; Polymorphonuclear leucocytes

Indexed keywords

GRANULOCYTE ANTIBODY; IODINE 125; PLASMIN; PLASMINOGEN; FIBRIN; FIBRINOGEN; PEPTIDE HYDROLASE; RADIOACTIVE IODINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CAROTID ARTERY THROMBOSIS; CELL DIVISION; CELL STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MODEL; FEMALE; FIBRINOGENOLYSIS; FIBRINOLYSIS; GENOTYPE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; JUGULAR VEIN; KNOCKOUT MOUSE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; VEIN THROMBOSIS; WILD TYPE; ANIMAL; CYTOCHEMISTRY; GENETICS; KINETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; THROMBOSIS;

ANIMALS; FIBRIN; FIBRINOGEN; GENOTYPE; HISTOCYTOCHEMISTRY; IODINE RADIOISOTOPES; KINETICS; MICE; MICE, KNOCKOUT; NEUTROPHILS; PEPTIDE HYDROLASES; PLASMINOGEN; THROMBOSIS;

EID: 0036847472     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613306     Document Type: Article

References (28)

1. Vassalli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J Clin Invest 1991; 88: 1067-72.
2. Weitz JI, Landman SL, Crowley KA, Birken S, Morgan FJ. Development of an assay for in vivo human neutrophil elastase activity. J Clin Invest 1986; 78: 155-62.
3. Plow E.F. The major fibrinolytic proteases of human leukocytes. Biochim Biophys Acta 1980; 630: 47-56.
4. Plow EF. Leukocyte elastase release during blood coagulation: A potential mechanism for activation of the alternative fibrinolytic pathway. J Clin Invest 1982; 69: 564-72.
5. Plow EF, Edgington TS. An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiological pH. J Clin Invest 1975; 56: 30-8.
6. Plow EF. The contribution of leukocyte proteases to fibrinolysis. Blut 1986; 53: 1-9.
7. Moroz LA. Nonplasmin-mediated fibrinolosis. Semin Thromb Hemost 1984; 10: 80-6.
8. Adams SA, Kelly SL, Kirsch RE, Robson SC, Shephard EG. Role of neutrophil membrane proteases in fibrin degradation. Blood Coagul Fibrinolysis 1995; 6: 693-702.
9. Ploplis VA, Carmeliet P, Vazirzadeh S, Van Vlaenderen I, Moons L, Plow EF, Collen D. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation 1995; 92: 2585-93.
10. Bugge TH, Flick MJ, Daugherty CC, Degen JL. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev 1995; 9: 794-807.
11. Kurz KD, Main BW, Sandusky GE. Rat model of arterial thrombosis induced by ferric chloride. Thromb Res 1990; 60: 269-80.
12. Farrehi PM, Ozaki CK, Carmeliet P, Fay WP. Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice. Circulation 1998; 97: 1002-8.
13. Lockyer S, Kambayashi J. Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis. J Cardiovasc Pharmacol 1999; 33: 718-25.
14. Marsh Lyle E, Lewis SD, Lehman ED, Gardell SJ, Motzel SL, Lynch JJ Jr. Assessment of thrombin inhibitor efficacy in a novel rabbit model of simultaneous arterial and venous thrombosis. Thromb Haemost 1998; 79: 656-62.
15. Presnell JK and Schreibman MP. Staining Hematological Elements and Related Tissues. In: Humason's Animal Tissue Techniques. Freeman WH. ed. San Francisco: The Johns Hopkins University Press 1997; 212-3.
16. Stockmans F, Stassen JM, Vermylen J, Hoylaerts MF, Nystrom A. A technique to investigate mural thrombus formation in small arteries and veins: I. Comparative morphometric and histological analysis. Ann Plast Surg 1997; 38: 56-62.
17. Fumagalli G, Angelaccio E, Lombardo N, Clementi F. Morphometric and ultrastructural study of experimental venous thrombosis. Effects of defibrotide, an antithrombotic agent. Haemostasis 1987; 17: 361-70.
18. Ploplis VA, French EL, Carmeliet P, Collen D, Plow EF. Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. Blood 1998; 91: 2005-9.
19. Simon DI, Ezratty AM, Francis SA, Rennke H, Loscalzo J. Fibrin(ogen) is internalized and degraded by activated human monocytoid cells via Mac-1 (CD11b/CD18): a nonplasmin fibrinolytic pathway. Blood 1993; 82: 2414-22.
20. Simon DI, Erzatty AM, Loscalzo J. The fibrin(ogen)olytic properties of cathepsin D. Biochemistry 1994; 33: 6555-63.
21. Thomas DP. Overview of venous thrombogenesis. Semin Thromb Hemost 1988; 14: 1-8.
22. Barnhart MI. Importance of neutrophilic leukocytes in the resolution of fibrin. Fed Proc 1965; 24: 846-53.
23. van Aken PJ, Emeis JJ. Organization of experimentally induced arterial thrombosis in rats: the first six days. Artery 1982; 11: 156-73.
24. Bilezikian SB; Nossel HL. Unique pattern of fibrinogen cleavage by human leukocyte proteases. Blood 1977; 50: 21-8.
25. Francis CW, Marder VJ. Degradation of cross-linked fibrin by human leukocyte proteases. J Lab Clin Med 1986; 107: 342-52.
26. Adams SA, Kelly SL, Kirsch RE et al. Role of neutrophil membrane proteases in fibrin gegradation. Blood Coagul Fibrinolysis 1995; 6: 693-702.
27. Kelly SL, Adama SA, Robson SC, et al. Fibrinogenolysis by a neutrophil membrane protease generates an Aα1-21 fragment. Biochem J 1994; 298: 689-95.
28. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994; 368: 419-24.